WebAntithrombotic therapy is used to reduce the risk of thromboembolic events in patients with conditions such as atrial fibrillation (AF), acute coronary syndrome (ACS), deep vein thrombosis (DVT), hypercoagulable states, and endoprostheses. Antithrombotics include medications classi-fied as anticoagulants or antiplatelet agents (APAs).
DA:12PA:16MOZ Rank:89
Management of antithrombotic agents for endoscopic …
WebAntithrombotic therapy is used to reduce the risk of thromboembolic events in patients with certain cardiovas-cular conditions (eg, atrial fibrillation and acute coronary syndrome), deep venous thrombosis (DVT), hypercoagu-lable states, and endoprostheses.
DA:19PA:69MOZ Rank:40
ASGE | Practice Guidelines - Standards of Practice
WebHere you will find ASGE guidelines for standards of practice. These range from recommendations on testing and screenings to the role of endoscopy in managing certain diagnoses to sedation and anesthesia to adverse events and quality indicators.
DA:82PA:63MOZ Rank:71
The management of antithrombotic agents for patients ... - PubMed
WebNov 24, 2015 · Antithrombotic therapy is used to reduce the risk of thromboembolic events in patients with conditions such as atrial fibrillation (AF), acute coronary syndrome (ACS), deep vein thrombosis (DVT), hypercoagulable states, and endoprostheses.
DA:7PA:42MOZ Rank:59
Management of patients on antithrombotic agents undergoing …
WebJan 13, 2018 · In contrast, the ASGE guidelines recommend withholding P2Y12 receptor inhibitors for at least 5–7 days before high-risk procedures. 1 We are concerned about the thrombotic risk of prolonged discontinuation of these antiplatelet drugs, especially in patients with DES.
DA:64PA:70MOZ Rank:95
ASGE Management of Antithrombotic Agents for Patients …
WebJan 1, 2016 · 312101. We recommend either: (1) 4-factor PCC and vitamin K or. (2) fresh frozen plasma be given for life-threatening GI bleeding in patients on warfarin anticoagulant therapy. Please note the ACCP advocates only option 1. The AHA/ACC supports option 1 or 2. (, ⊕⊕⊕o) 312101. We suggest endoscopic therapy not be delayed in patients with ...
WebThe mechanism of action of aspirin in low doses is inhibition of cyclooxygenase and platelet generation of thromboxane A2, resulting in an antithrombotic effect.
DA:15PA:55MOZ Rank:99
ASGE issues guidelines on management of antithrombotic …
WebDecember 8 2009. According to a new guideline from the American Society for Gastrointestinal Endoscopy (ASGE) regarding the management of antithrombotic agents for endoscopy, aspirin and/or...
DA:30PA:47MOZ Rank:81
The management of antithrombotic agents for patients …
WebThe Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy (ASGE) prepared this text. In preparing this guideline, a search of the medical literature was performed using PubMed and the Cochrane Database, with dates of search from August 1966 to December 2014.
